Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16(Suppl1):S27-36.

PubMed  PubMed Central  Google Scholar 

Garg V, Bose A, Jindal J, Goyal A. Comparison of clinical presentation and risk factors in diabetic and non-diabetic females with urinary tract infection assessed as per the European Association of Urology Classification. J Clin Diagn Res. 2015;9(6):PC12-4.

PubMed  PubMed Central  Google Scholar 

Grigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA. 2014;312(16):1677–84.

Article  PubMed  Google Scholar 

Fu AZ, Iglay K, Qiu Y, Engel S, Shankar R, Brodovicz K. Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes. J Diabetes Complicat. 2014;28(6):805–10.

Article  Google Scholar 

Sewify M, Nair S, Warsame S, Murad M, Alhubail A, Behbehani K, et al. Prevalence of urinary tract infection and antimicrobial susceptibility among diabetic patients with controlled and uncontrolled glycemia in Kuwait. J Diabetes Res. 2016;2016:6573215.

Article  PubMed  Google Scholar 

Nichols GA, Brodovicz KG, Kimes TM, Déruaz-Luyet A, Bartels DB. Prevalence and incidence of urinary tract and genital infections among patients with and without type 2 diabetes. J Diabetes Complicat. 2017;31(11):1587–91.

Article  Google Scholar 

Wilke T, Boettger B, Berg B, Groth A, Mueller S, Botteman M, et al. Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: an analysis based on a large sample of 456,586 German T2DM patients. J Diabetes Complicat. 2015;29(8):1015–23.

Article  Google Scholar 

Hirji I, Guo Z, Andersson SW, Hammar N, Gomez-Caminero A. Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD). J Diabetes Complicat. 2012;26(6):513–6.

Article  Google Scholar 

MeC R-M, Pascual-Pérez R, Orozco-Beltrán D, Pérez-Barba C, Pedrera-Carbonell V. Risk factors for the development and persistence of asymptomatic bacteriuria in patients with type 2 diabetes. Med Clin (Barc). 2005;125(16):606–10.

Google Scholar 

Janifer J, Geethalakshmi S, Satyavani K, Viswanathan V. Prevalence of lower urinary tract infection in South Indian type 2 diabetic subjects. Indian J Nephrol. 2009;19(3):107–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goswami R, Bal CS, Tejaswi S, Punjabi GV, Kapil A, Kochupillai N. Prevalence of urinary tract infection and renal scars in patients with diabetes mellitus. Diabetes Res Clin Pract. 2001;53(3):181–6.

Article  CAS  PubMed  Google Scholar 

Tourret J, Bagnis CI, Denamur E. Urinary tract infections in diabetic patients. Rev Prat. 2014;64(7):980–3.

PubMed  Google Scholar 

Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf. 2010;19(12):1287–92.

Article  PubMed  Google Scholar 

Boroumand MA, Sam L, Abbasi SH, Salarifar M, Kassaian E, Forghani S. Asymptomatic bacteriuria in type 2 Iranian diabetic women: a cross sectional study. BMC Womens Health. 2006;6:4.

Article  PubMed  PubMed Central  Google Scholar 

de Lastours V, Foxman B. Urinary tract infection in diabetes: epidemiologic considerations. Curr Infect Dis Rep. 2014;16(1):389.

Article  PubMed  Google Scholar 

Zhanel GG, Harding GK, Nicolle LE. Asymptomatic bacteriuria in patients with diabetes mellitus. Rev Infect Dis. 1991;13(1):150–4.

Article  CAS  PubMed  Google Scholar 

Harwalkar A, Gupta S, Rao A, Srinivasa H. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus. Trans R Soc Trop Med Hyg. 2015;109(12):769–74.

CAS  PubMed  Google Scholar 

Lye WC, Chan RK, Lee EJ, Kumarasinghe G. Urinary tract infections in patients with diabetes mellitus. J Infect. 1992;24(2):169–74.

Article  CAS  PubMed  Google Scholar 

Bonadio M, Costarelli S, Morelli G, Tartaglia T. The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis. 2006;6:54.

Article  PubMed  PubMed Central  Google Scholar 

Chen HS, Su LT, Lin SZ, Sung FC, Ko MC, Li CY. Increased risk of urinary tract calculi among patients with diabetes mellitus–a population-based cohort study. Urology. 2012;79(1):86–92.

Article  PubMed  Google Scholar 

James R, Hijaz A. Lower urinary tract symptoms in women with diabetes mellitus: a current review. Curr Urol Rep. 2014;15(10):440.

Article  PubMed  Google Scholar 

Geerlings SE. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents. 2008;31(Suppl 1):S54–7.

Article  CAS  PubMed  Google Scholar 

Hoepelman IM. Urinary tract infection in patients with diabetes mellitus. Int J Antimicrob Agents. 1994;4(2):113–6.

Article  CAS  PubMed  Google Scholar 

Hoepelman AI, Meiland R, Geerlings SE. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents. 2003;22(Suppl 2):35–43.

Article  PubMed  Google Scholar 

Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015;8:129–36.

PubMed  PubMed Central  Google Scholar 

Chen SL, Jackson SL, Boyko EJ. Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models. J Urol. 2009;182(6 Suppl):S51–6.

PubMed  Google Scholar 

Geerlings SE, Meiland R, Hoepelman IM. Urinary tract infections in women with diabetes mellitus. Ned Tijdschr Geneeskd. 2001;145(38):1832–6.

CAS  PubMed  Google Scholar 

Geerlings SE, Stolk RP, Camps MJ, Netten PM, Collet TJ, Hoepelman AI, et al. Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care. 2000;23(12):1737–41.

Article  CAS  PubMed  Google Scholar 

Al-Rubeaan KA, Moharram O, Al-Naqeb D, Hassan A, Rafiullah MR. Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. World J Urol. 2013;31(3):573–8.

Article  PubMed  Google Scholar 

Sanden AK, Johansen MB, Pedersen L, Lervang HH, Schønheyder HC, Thomsen RW. Change from oral antidiabetic therapy to insulin and risk of urinary tract infections in type 2 diabetic patients: a population-based prescription study. J Diabetes Complicat. 2010;24(6):375–81.

Article  Google Scholar 

NjomnangSoh P, Vidal F, Huyghe E, Gourdy P, Halimi JM, Bouhanick B. Urinary and genital infections in patients with diabetes: how to diagnose and how to treat. Diabetes Metab. 2016;42(1):16–24.

Article  CAS  Google Scholar 

•• Benjamin T, Schumacher C. Characterization of risk factors for genitourinary infections with sodium-glucose cotransporter-2 inhibitors. Pharmacotherapy. 2020;40(10):1002–11.While certain factors like estimated glomerular filtration rate (eGFR) and a history of genitourinary infections increase the risk, the overall incidence of infections related to SGLT2 inhibitors might be lower than initially suggested.

Article  CAS  PubMed  Google Scholar 

•• Staplin N, Roddick AJ, Emberson J, Reith C, Riding A, Wonnacott A, et al. Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials. EClinicalMedicine. 2021;41:101163.The observed impacts of SGLT-2 inhibition on essential safety and effectiveness outcomes remain consistent among various patient groups studied.

Article  PubMed  PubMed Central  Google Scholar 

Schneeberger C, Kazemier BM, Geerlings SE. Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr Opin Infect Dis. 2014;27(1):108–14.

Article  PubMed  Google Scholar 

Aggarwal A, Wadhwa R, Kapoor D, Khanna R. High prevalence of genital mycotic infections with sodium-glucose co-transporter 2 inhibitors among Indian patients with type 2 diabetes. Indian J Endocrinol Metab. 2019;23(1):9–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dave CV, Schneeweiss S, Kim D, Fralick M, Tong A, Patorno E. Sodium-glucose cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study. Ann Intern Med. 2019;171(4):248–56.

Article  PubMed  PubMed Central  Google Scholar 

Rizzi M, Trevisan R. Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors. Nutr Metab Cardiovasc Dis. 2016;26(11):963–70.

Article  CAS  PubMed  Google Scholar 

•• Wiegley N, So PN. Sodium-glucose cotransporter 2 inhibitors and urinary tract infection: is there room for real concern? Kidney360. 2022;3(11):1991–3.This study serves as a pivotal resource providing reassurance to both patients and prescribers, thereby advocating for the broader and confident utilization of SGLT-2 I in clinical practice for enhanced kidney and heart protection.

Halimi S, Vergès B. Adverse effects and safety of SGLT-2 inhibitors. Diabetes Metab. 2014;40(6 Suppl 1):S28-34.

Article  CAS  PubMed  Google Scholar 

Yang H, Choi E, Park E, Na E, Chung SY, Kim B, et al. Risk of genital and urinary tract infections associated with SGLT-2 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes mellitus: a retrospective cohort study in Korea. Pharmacol Res Perspect. 2022;10(1):e00910.

Article  CAS  PubMed  PubMed Central